NO20052999L - Ny synergistisk kombinasjon omfattende roflumilast og formoterol - Google Patents

Ny synergistisk kombinasjon omfattende roflumilast og formoterol

Info

Publication number
NO20052999L
NO20052999L NO20052999A NO20052999A NO20052999L NO 20052999 L NO20052999 L NO 20052999L NO 20052999 A NO20052999 A NO 20052999A NO 20052999 A NO20052999 A NO 20052999A NO 20052999 L NO20052999 L NO 20052999L
Authority
NO
Norway
Prior art keywords
formoterol
combination including
synergistic combination
new synergistic
roflumilast
Prior art date
Application number
NO20052999A
Other languages
English (en)
Other versions
NO334247B1 (no
Inventor
Norbert Kolassa
Rolf Beume
Degenhard Marx
Daniela Bundschuh
Christian Weimar
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of NO20052999L publication Critical patent/NO20052999L/no
Publication of NO334247B1 publication Critical patent/NO334247B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen vedrører den kombinerte administtasjon av roflumilast og formoterol for behandlingen av lidelser i det respiratoriske system.
NO20052999A 2002-11-27 2005-06-17 Medikament omfattende roflumilast i kombinasjon med formoterol NO334247B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026505 2002-11-27
PCT/EP2003/013275 WO2004047829A1 (en) 2002-11-27 2003-11-26 New synergistic combination comprising roflumilast and formoterol

Publications (2)

Publication Number Publication Date
NO20052999L true NO20052999L (no) 2005-06-17
NO334247B1 NO334247B1 (no) 2014-01-20

Family

ID=32338002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052999A NO334247B1 (no) 2002-11-27 2005-06-17 Medikament omfattende roflumilast i kombinasjon med formoterol

Country Status (31)

Country Link
US (1) US20060142308A1 (no)
EP (1) EP1567139B1 (no)
JP (1) JP2006508994A (no)
KR (1) KR101071798B1 (no)
CN (1) CN100346777C (no)
AT (1) ATE399543T1 (no)
AU (1) AU2003292120B2 (no)
BR (1) BR0316451A (no)
CA (1) CA2506962C (no)
CO (1) CO5690570A2 (no)
CY (1) CY1110369T1 (no)
DE (1) DE60321953D1 (no)
DK (1) DK1567139T3 (no)
EA (1) EA009935B1 (no)
ES (1) ES2309357T3 (no)
HR (1) HRP20050579B1 (no)
IL (1) IL168308A (no)
IS (1) IS2575B (no)
MA (1) MA27539A1 (no)
ME (1) ME00489B (no)
MX (1) MXPA05005437A (no)
NO (1) NO334247B1 (no)
NZ (1) NZ540659A (no)
PL (1) PL216752B1 (no)
PT (1) PT1567139E (no)
RS (1) RS51081B (no)
SI (1) SI1567139T1 (no)
TN (1) TNSN05131A1 (no)
UA (1) UA83018C2 (no)
WO (1) WO2004047829A1 (no)
ZA (1) ZA200503308B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
AU2006224619B2 (en) * 2005-03-16 2012-06-07 Takeda Gmbh Taste masked dosage form containing roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
ES2378281T3 (es) * 2006-07-05 2012-04-10 Nycomed Gmbh Combinación de atorvastatina con un inhibidor de fosfodiesterasa 4 para el tratamiento de neumopatías inflamatorias
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
US20130172303A1 (en) * 2012-01-03 2013-07-04 Forest Laboratories Holdings Ltd. Roflumilast compositions for the treatment of copd
LT2948148T (lt) * 2013-01-28 2020-12-28 Incozen Therapeutics Pvt. Ltd. Autoimuninių, kvėpavimo ir uždegiminių sutrikimų gydymo būdai, įkvėpiant roflumilasto n-oksidą
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
DE59410119D1 (de) * 1993-07-02 2002-06-20 Byk Gulden Lomberg Chem Fab Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
DE69835594T2 (de) * 1997-02-17 2007-08-16 Altana Pharma Ag Zusammensetzungen zur behandlung von irds oder ards die 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten
DK0975347T3 (da) * 1997-02-28 2008-06-16 Nycomed Gmbh Synergistisk kombination af PDE-inhibitorer og adenylatcyclase-agonister eller guanylcyclyseagonister
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
CZ293735B6 (cs) * 1998-08-26 2004-07-14 Smithkline Beecham Corporation Farmaceutický prostředek pro léčbu plicní nemoci
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
CA2715683A1 (en) * 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
WO2002076933A1 (en) * 2001-03-22 2002-10-03 Glaxo Group Limited Formailide derivatives as beta2-adrenoreceptor agonists
WO2002088167A1 (en) * 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha

Also Published As

Publication number Publication date
CY1110369T1 (el) 2015-04-29
AU2003292120A1 (en) 2004-06-18
RS20050382A (sr) 2007-08-03
DE60321953D1 (de) 2008-08-14
NO334247B1 (no) 2014-01-20
CO5690570A2 (es) 2006-10-31
AU2003292120B2 (en) 2010-01-21
WO2004047829A1 (en) 2004-06-10
ES2309357T3 (es) 2008-12-16
NZ540659A (en) 2007-05-31
CN100346777C (zh) 2007-11-07
CA2506962C (en) 2012-01-03
IS7898A (is) 2005-06-20
HRP20050579A2 (hr) 2006-04-30
ATE399543T1 (de) 2008-07-15
EA200500774A1 (ru) 2005-12-29
US20060142308A1 (en) 2006-06-29
EP1567139A1 (en) 2005-08-31
CA2506962A1 (en) 2004-06-10
UA83018C2 (uk) 2008-06-10
MXPA05005437A (es) 2005-08-03
MA27539A1 (fr) 2005-09-01
WO2004047829A8 (en) 2005-06-30
DK1567139T3 (da) 2008-11-03
IL168308A (en) 2010-12-30
SI1567139T1 (sl) 2008-12-31
IS2575B (is) 2010-02-15
ME00489B (me) 2011-10-10
JP2006508994A (ja) 2006-03-16
TNSN05131A1 (en) 2007-05-14
HK1081861A1 (en) 2006-05-26
KR20050085104A (ko) 2005-08-29
CN1713903A (zh) 2005-12-28
KR101071798B1 (ko) 2011-10-11
HRP20050579B1 (hr) 2014-01-31
RS51081B (sr) 2010-10-31
PL216752B1 (pl) 2014-05-30
ZA200503308B (en) 2006-11-29
BR0316451A (pt) 2005-10-11
PL377732A1 (pl) 2006-02-06
PT1567139E (pt) 2008-10-01
EA009935B1 (ru) 2008-04-28
EP1567139B1 (en) 2008-07-02

Similar Documents

Publication Publication Date Title
MXPA05006670A (es) Administracion de capsaicinoides.
DK1587506T3 (da) Administration af capsaicinoider
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
DE60026855D1 (de) Synergistische kombination von roflumilast und salmeterol
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
NO20052420L (no) Farmakologisk behandling av sovnapn±.
NO20064964L (no) Behandling av svekket respiratorisk funksjon
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
NO20045344L (no) Kombinasjon for behandling av luftveisforstyrrelser
EA200500538A1 (ru) Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

MM1K Lapsed by not paying the annual fees